THE US Food and Drug Authority
has approved a new indication for
Natazia (estradiol valerate and
estradiol valerate/dienogest), for
the treatment of heavy menstrual
bleeding that is not caused by any
diagnosed conditions of the uterus,
in women who choose an oral
contraceptive for contraception.
See www.fda.gov for details.The above article was sent to subscribers in Pharmacy Daily's issue from 16 Mar 12 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Mar 12
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.